User contributions
- 13:38, 26 September 2024 diff hist +11,959 N Hickszamora3560 Created page with "progression free survival remains the most common endpoint in phase III trials.<br /><br /> The association of primary oncologist specialty, medical oncology versus gynecologi..." current